QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J.-Y. Articles by Koh, J.-Y. Search for Related Content PubMed PubMed Citation Articles by Lee, J.-Y. Articles by Koh, J.-Y.

 Previous Article  |  Next Article 

The Journal of Neuroscience, 2001, 21:RC171:1-6

RAPID COMMUNICATION
Protection by Pyruvate against Transient Forebrain Ischemia in Rats

Joo-Yong Lee, Yang-Hee Kim, and Jae-Young Koh

National Creative Research Initiative Center for the Study of CNS Zinc and Department of Neurology, University of Ulsan College of Medicine, Seoul 138-736, Korea

Pyruvate has a remarkable protective effect against zinc neurotoxicity. Because zinc neurotoxicity is likely one of the key mechanisms of ischemic brain injury, the neuroprotective effect of pyruvate was tested in a rat model of transient forebrain ischemia. Control experiments in mouse cortical culture showed that pyruvate almost completely blocked zinc toxicity but did not attenuate calcium-overload neuronal death. Adult rats subjected to 12 min forebrain ischemia exhibited widespread zinc accumulation and neuronal death throughout hippocampus and cortex 72 hr after reperfusion. However, rats injected intraperitoneally with sodium pyruvate (500-1000 mg/kg) within 1 hr after 12 min forebrain ischemia showed almost no neuronal death. In addition, the mortality was markedly decreased in the pyruvate-protected groups (3.8%) compared with the NaCl-injected control group (58.1%). The neuroprotective effect persisted even at 30 d after the insult. The spectacular protection without noticeable side effects makes pyruvate a promising neuroprotectant in human ischemic stroke.

Key words: zinc neurotoxicity; glycolysis; excitotoxicity; glutamate antagonist; stroke; ATP; NAD⁺

---

Copyright © Society for Neuroscience  0270-6474//$05.00/0

This article has been cited by other articles:

				E. Hinoi, T. Takarada, Y. Tsuchihashi, S. Fujimori, N. Moriguchi, L. Wang, K. Uno, and Y. Yoneda A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts Mol. Pharmacol., September 1, 2006; 70(3): 925 - 935. [Abstract] [Full Text] [PDF]

				Y.-M. Yu, J.-B. Kim, K.-W. Lee, S. Yun Kim, P.-L. Han, and J.-K. Lee Inhibition of the Cerebral Ischemic Injury by Ethyl Pyruvate With a Wide Therapeutic Window Stroke, October 1, 2005; 36(10): 2238 - 2243. [Abstract] [Full Text] [PDF]

				S. W. Suh, K. Aoyama, Y. Matsumori, J. Liu, and R. A. Swanson Pyruvate Administered After Severe Hypoglycemia Reduces Neuronal Death and Cognitive Impairment Diabetes, May 1, 2005; 54(5): 1452 - 1458. [Abstract] [Full Text] [PDF]

				X. Q. Wang, A. Y. Xiao, C. Sheline, K. Hyrc, A. Yang, M. P. Goldberg, D. W. Choi, and S. Ping Yu Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress J. Cell Sci., May 15, 2003; 116(10): 2099 - 2110. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help